{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T00:25:21Z","timestamp":1759623921822,"version":"build-2065373602"},"reference-count":97,"publisher":"Japanese Association of Virology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Uirusu"],"published-print":{"date-parts":[[2025]]},"DOI":"10.2222\/jsv.75.13","type":"journal-article","created":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T22:08:22Z","timestamp":1759097302000},"page":"13-22","source":"Crossref","is-referenced-by-count":0,"title":["Measles virus","\u9ebb\u75b9\u30a6\u30a4\u30eb\u30b9"],"prefix":"10.2222","volume":"75","author":[{"given":"Fumio","family":"SEKI","sequence":"first","affiliation":[{"name":"Department of Respiratory Viruses, National Institute of Infectious Diseases, Japan Institute for Health Security, Musashimurayama, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"TAKEDA","sequence":"additional","affiliation":[{"name":"Graduate School of Medicine and Faculty of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1062","reference":[{"key":"1","unstructured":"\uff11\uff09Ministry of Health LaW. Measles. 2024. https:\/\/id-info.jihs.go.jp\/surveillance\/iasr\/45\/535\/535.pdf."},{"key":"2","doi-asserted-by":"crossref","unstructured":"\uff12\uff09Minta AA, Ferrari M, Antoni S, et al. Progress Toward Measles Elimination - Worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep 2024; 73(45): 1036-42.","DOI":"10.15585\/mmwr.mm7345a4"},{"key":"3","unstructured":"\uff13\uff09Kuhn JH, Abe J, Adkins S, et al. Annual (2023) taxonomic update of RNA-directed RNA polymerase-encoding negative-sense RNA viruses (realm Riboviria: kingdom Orthornavirae: phylum Negarnaviricota). J Gen Virol 2023; 104(8)."},{"key":"4","unstructured":"\uff14\uff09Postler TS, Clawson AN, Amarasinghe GK, et al. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. Syst Biol 2017; 66(3): 463-73."},{"key":"5","doi-asserted-by":"crossref","unstructured":"\uff15\uff09Rima B, Balkema-Buschmann A, Dundon WG, et al. ICTV Virus Taxonomy Profile: Paramyxoviridae. J Gen Virol 2019; 100(12): 1593-4.","DOI":"10.1099\/jgv.0.001328"},{"key":"6","doi-asserted-by":"crossref","unstructured":"\uff16\uff09Heider A, Santibanez S, Tischer A, et al. Comparative investigation of the long non-coding M-F genome region of wild-type and vaccine measles viruses. Arch Virol 1997; 142(12): 2521-8.","DOI":"10.1007\/s007050050259"},{"key":"7","doi-asserted-by":"crossref","unstructured":"\uff17\uff09Takeda M, Ohno S, Seki F, Nakatsu Y, Tahara M, Yanagi Y. Long untranslated regions of the measles virus M and F genes control virus replication and cytopathogenicity. J Virol 2005; 79(22): 14346-54.","DOI":"10.1128\/JVI.79.22.14346-14354.2005"},{"key":"8","doi-asserted-by":"crossref","unstructured":"\uff18\uff09Anderson DE, von Messling V. Region between the canine distemper virus M and F genes modulates virulence by controlling fusion protein expression. J Virol 2008; 82(21): 10510-8.","DOI":"10.1128\/JVI.01419-08"},{"key":"9","doi-asserted-by":"crossref","unstructured":"\uff19\uff09Penedos AR, Myers R, Hadef B, Aladin F, Brown KE. Assessment of the Utility of Whole Genome Sequencing of Measles Virus in the Characterisation of Outbreaks. PLoS One 2015; 10(11): e0143081.","DOI":"10.1371\/journal.pone.0143081"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10\uff09Tomalty E, Mercier E, Pisharody L, et al. Detection of Measles Virus Genotype A in a Non-Endemic Wastewater Setting: Insights from Measles Wastewater and Environmental Monitoring in Canada's Capital Region. Environ Sci Technol Lett 2025; 12(2): 124-9.","DOI":"10.1021\/acs.estlett.4c00945"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11\uff09Rector A, Bloemen M, Hoorelbeke B, Van Ranst M, Wollants E. Detection of Measles Virus Genotype D8 in Wastewater of the Brussels Capital Region, Belgium. J Med Virol 2025; 97(2): e70251.","DOI":"10.1002\/jmv.70251"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12\uff09Kim YT, Lee K, Lee H, et al. Development of a wastewater based infectious disease surveillance research system in South Korea. Sci Rep 2024; 14(1): 24544.","DOI":"10.1038\/s41598-024-76614-4"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13\uff09Riddell MA, Moss WJ, Hauer D, Monze M, Griffin DE. Slow clearance of measles virus RNA after acute infection. J Clin Virol 2007; 39(4): 312-7.","DOI":"10.1016\/j.jcv.2007.05.006"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14\uff09Griffin DE. The Immune Response in Measles: Virus Control, Clearance and Protective Immunity. Viruses 2016; 8(10).","DOI":"10.3390\/v8100282"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15\uff09Griffin DE. Measles virus persistence and its consequences. Curr Opin Virol 2020; 41: 46-51.","DOI":"10.1016\/j.coviro.2020.03.003"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16\uff09Montroy J, Yan C, Khan F, et al. Post-exposure prophylaxis for the prevention of measles: A systematic review. Vaccine 2025; 47: 126706.","DOI":"10.1016\/j.vaccine.2025.126706"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17\uff09Moss WJ. Measles. Lancet 2017; 390(10111): 2490-502.","DOI":"10.1016\/S0140-6736(17)31463-0"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18\uff09Stein RA. Hypoxic respiratory failure in measles-associated pneumonia. Int J Clin Pract 2020; 74(2): e13456.","DOI":"10.1111\/ijcp.13456"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19\uff09Mina MJ, Kula T, Leng Y, et al. Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science 2019; 366(6465): 599-606.","DOI":"10.1126\/science.aay6485"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20\uff09Laksono BM, Grosserichter-Wagener C, de Vries RD, et al. In Vitro Measles Virus Infection of Human Lymphocyte Subsets Demonstrates High Susceptibility and Permissiveness of both Naive and Memory B Cells. J Virol 2018; 92(8).","DOI":"10.1128\/JVI.00131-18"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21\uff09Laksono BM, de Vries RD, Verburgh RJ, et al. Studies into the mechanism of measles-associated immune suppression during a measles outbreak in the Netherlands. Nat Commun 2018; 9(1): 4944.","DOI":"10.1038\/s41467-018-07515-0"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22\uff09Tatsuo H, Ono N, Tanaka K, Yanagi Y. [The cellular receptor for measles virus: SLAM (CDw 150)]. Uirusu 2000; 50(2): 289-96.","DOI":"10.2222\/jsv.50.289"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23\uff09Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406(6798): 893-7.","DOI":"10.1038\/35022579"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24\uff09Muhlebach MD, Mateo M, Sinn PL, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480(7378): 530-3.","DOI":"10.1038\/nature10639"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25\uff09Noyce RS, Bondre DG, Ha MN, et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog 2011; 7(8): e1002240.","DOI":"10.1371\/journal.ppat.1002240"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26\uff09Delpeut S, Sawatsky B, Wong XX, Frenzke M, Cattaneo R, von Messling V. Nectin-4 Interactions Govern Measles Virus Virulence in a New Model of Pathogenesis, the Squirrel Monkey (Saimiri sciureus). J Virol 2017; 91(11).","DOI":"10.1128\/JVI.02490-16"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27\uff09Erlenhofer C, Duprex WP, Rima BK, Ter Meulen V, Schneider-Schaulies J. Analysis of receptor (CD46, CD150) usage by measles virus. J Gen Virol 2002; 83(Pt 6): 1431-6.","DOI":"10.1099\/0022-1317-83-6-1431"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28\uff09Tahara M, Takeda M, Seki F, Hashiguchi T, Yanagi Y. Multiple amino acid substitutions in hemagglutinin are necessary for wild-type measles virus to acquire the ability to use receptor CD46 efficiently. J Virol 2007; 81(6): 2564-72.","DOI":"10.1128\/JVI.02449-06"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29\uff09de Swart RL, Ludlow M, de Witte L, et al. Predominant infection of CD150+ lymphocytes and dendritic cells during measles virus infection of macaques. PLoS Pathog 2007; 3(11): e178.","DOI":"10.1371\/journal.ppat.0030178"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30\uff09Lemon K, de Vries RD, Mesman AW, et al. Early target cells of measles virus after aerosol infection of non-human primates. PLoS Pathog 2011; 7(1): e1001263.","DOI":"10.1371\/journal.ppat.1001263"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31\uff09Derakhshani S, Kurz A, Japtok L, et al. Measles Virus Infection Fosters Dendritic Cell Motility in a 3D Environment to Enhance Transmission to Target Cells in the Respiratory Epithelium. Front Immunol 2019; 10: 1294.","DOI":"10.3389\/fimmu.2019.01294"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32\uff09Ludlow M, Lemon K, de Vries RD, et al. Measles virus infection of epithelial cells in the macaque upper respiratory tract is mediated by subepithelial immune cells. J Virol 2013; 87(7): 4033-42.","DOI":"10.1128\/JVI.03258-12"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33\uff09Shirogane Y, Takemoto R, Suzuki T, et al. CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Acting in cis. J Virol 2021; 95(14): e0052821.","DOI":"10.1128\/JVI.00528-21"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34\uff09Takemoto R, Suzuki T, Hashiguchi T, Yanagi Y, Shirogane Y. Short-Stalk Isoforms of CADM1 and CADM2 Trigger Neuropathogenic Measles Virus-Mediated Membrane Fusion by Interacting with the Viral Hemagglutinin. J Virol 2022; 96(3): e0194921.","DOI":"10.1128\/jvi.01949-21"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35\uff09Shirogane Y, Hashiguchi T, Yanagi Y. Weak cis and trans Interactions of the Hemagglutinin with Receptors Trigger Fusion Proteins of Neuropathogenic Measles Virus Isolates. J Virol 2020; 94(2).","DOI":"10.1128\/JVI.01727-19"},{"key":"36","unstructured":"36\uff09Organization WH. Measles virus nomenclature update: 2012. Wkly Epidemiol Rec 2012; 87(9): 73-81."},{"key":"37","unstructured":"37\uff09Organization WH. Update of the nomenclature for describing the genetic characteristics of wild-type measles viruses: new genotypes and reference strains. Wkly Epidemiol Rec 2003; 78(27): 229-32."},{"key":"38","doi-asserted-by":"crossref","unstructured":"38\uff09Brown KE, Rota PA, Goodson JL, et al. Genetic Characterization of Measles and Rubella Viruses Detected Through Global Measles and Rubella Elimination Surveillance, 2016-2018. MMWR Morb Mortal Wkly Rep 2019; 68(26): 587-91.","DOI":"10.15585\/mmwr.mm6826a3"},{"key":"39","unstructured":"39\uff09D. Williams AP, B. Bankamp, R. Anderson, J. H\u00fcbschen, M. Ben Mamou, A. Beck, D. Brown, G. Rey, R. Evans,A. Ghoniem, L. Sangal, C. Byabamazima, A. Dosseh, A. Kfutwah, M. Mulders, K. Browna and PA. Rota. Update: circulation of active genotypes of measles virus and recommendations for use of sequence analysis to monitor viral transmission. Weekly epidemiological record 2022; 97: 485-92."},{"key":"40","doi-asserted-by":"crossref","unstructured":"40\uff09Minta AA, Ferrari M, Antoni S, et al. Progress Toward Measles Elimination - Worldwide, 2000-2022. MMWR Morb Mortal Wkly Rep 2023; 72(46): 1262-8.","DOI":"10.15585\/mmwr.mm7246a3"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41\uff09Rota PA, Brown K, Mankertz A, et al. Global distribution of measles genotypes and measles molecular epidemiology. J Infect Dis 2011; 204 Suppl 1: S514-23.","DOI":"10.1093\/infdis\/jir118"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42\uff09Wang H, Zhu Z, Duan X, et al. Transmission Pattern of Measles Virus Circulating in China During 1993-2021: Genotyping Evidence Supports That China Is Approaching Measles Elimination. Clin Infect Dis 2023; 76(3): e1140-e9.","DOI":"10.1093\/cid\/ciac674"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43\uff09Jacqueline C, Gavilan AM, Lopez-Perea N, et al. Utility of MF-non coding region for measles molecular surveillance during post-elimination phase, Spain, 2017-2020. Front Microbiol 2023; 14: 1143933.","DOI":"10.3389\/fmicb.2023.1143933"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44\uff09Hiebert J, Zubach V, Schulz H, Severini A. Genomic tools for post-elimination measles molecular epidemiology using Canadian surveillance data from 2018-2020. Front Microbiol 2024; 15: 1475144.","DOI":"10.3389\/fmicb.2024.1475144"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45\uff09Kim JM, Park S, Kim S, Park KR, Wang JS, Chung YS. Genetic Analysis of the Measles Virus From the Outbreaks in South Korea, 2019. Front Microbiol 2021; 12: 763107.","DOI":"10.3389\/fmicb.2021.763107"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46\uff09Bankamp B, Kim G, Hart D, et al. Global Update on Measles Molecular Epidemiology. Vaccines (Basel) 2024; 12(7).","DOI":"10.3390\/vaccines12070810"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47\uff09Perez-Rodriguez FJ, Cherpillod P, Thomasson V, Vetter P, Schibler M. Identification of a measles variant displaying mutations impacting molecular diagnostics, Geneva, Switzerland, 2023. Euro Surveill 2024; 29(5).","DOI":"10.2807\/1560-7917.ES.2024.29.5.2400034"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48\uff09Beck AS, Lopareva EN, Hwang H, et al. Evaluation of the sensitivity of a measles diagnostic real-time RT-PCR assay incorporating recently observed priming mismatch variants, 2024. Euro Surveill 2024; 29(28).","DOI":"10.2807\/1560-7917.ES.2024.29.28.2400410"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49\uff09Beaty SM, Lee B. Constraints on the Genetic and Antigenic Variability of Measles Virus. Viruses 2016; 8(4): 109.","DOI":"10.3390\/v8040109"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50\uff09de Swart RL, Yuksel S, Langerijs CN, Muller CP, Osterhaus A. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies. J Gen Virol 2009; 90(Pt 12): 2982-9.","DOI":"10.1099\/vir.0.014944-0"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51\uff09de Swart RL, Yuksel S, Osterhaus AD. Relative contributions of measles virus hemagglutinin- and fusion protein-specific serum antibodies to virus neutralization. J Virol 2005; 79(17): 11547-51.","DOI":"10.1128\/JVI.79.17.11547-11551.2005"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52\uff09Navaratnarajah CK, Kumar S, Generous A, Apte-Sengupta S, Mateo M, Cattaneo R. The measles virus hemagglutinin stalk: structures and functions of the central fusion activation and membrane-proximal segments. J Virol 2014; 88(11): 6158-67.","DOI":"10.1128\/JVI.02846-13"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53\uff09Hashiguchi T, Kajikawa M, Maita N, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A 2007; 104(49): 19535-40.","DOI":"10.1073\/pnas.0707830104"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54\uff09Zhang X, Lu G, Qi J, et al. Structure of measles virus hemagglutinin bound to its epithelial receptor nectin-4. Nat Struct Mol Biol 2013; 20(1): 67-72.","DOI":"10.1038\/nsmb.2432"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55\uff09Hashiguchi T, Ose T, Kubota M, et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol 2011; 18(2): 135-41.","DOI":"10.1038\/nsmb.1969"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56\uff09Santiago C, Celma ML, Stehle T, Casasnovas JM. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol 2010; 17(1): 124-9.","DOI":"10.1038\/nsmb.1726"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57\uff09Navaratnarajah CK, Oezguen N, Rupp L, et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol 2011; 18(2): 128-34.","DOI":"10.1038\/nsmb.1967"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58\uff09Tahara M, Ohno S, Sakai K, et al. The receptor-binding site of the measles virus hemagglutinin protein itself constitutes a conserved neutralizing epitope. J Virol 2013; 87(6): 3583-6.","DOI":"10.1128\/JVI.03029-12"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59\uff09Finsterbusch T, Wolbert A, Deitemeier I, et al. Measles viruses of genotype H1 evade recognition by vaccine-induced neutralizing antibodies targeting the linear haemagglutinin noose epitope. J Gen Virol 2009; 90(Pt 11): 2739-45.","DOI":"10.1099\/vir.0.013524-0"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60\uff09Bianchi S, Canuti M, Ciceri G, et al. Molecular Epidemiology of B3 and D8 Measles Viruses through Hemagglutinin Phylogenetic History. Int J Mol Sci 2020; 21(12).","DOI":"10.3390\/ijms21124435"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61\uff09Munoz-Alia MA, Muller CP, Russell SJ. Antigenic Drift Defines a New D4 Subgenotype of Measles Virus. J Virol 2017; 91(11).","DOI":"10.1128\/JVI.00209-17"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62\uff09Bianchi S, Gori M, Fappani C, et al. Characterization of Vaccine Breakthrough Cases during Measles Outbreaks in Milan and Surrounding Areas, Italy, 2017-2021. Viruses 2022; 14(5).","DOI":"10.3390\/v14051068"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63\uff09Tahara M, Burckert JP, Kanou K, Maenaka K, Muller CP, Takeda M. Measles Virus Hemagglutinin Protein Epitopes: The Basis of Antigenic Stability. Viruses 2016; 8(8).","DOI":"10.3390\/v8080216"},{"key":"64","doi-asserted-by":"crossref","unstructured":"64\uff09Munoz-Alia MA, Nace RA, Zhang L, Russell SJ. Serotypic evolution of measles virus is constrained by multiple co-dominant B cell epitopes on its surface glycoproteins. Cell Rep Med 2021; 2(4): 100225.","DOI":"10.1016\/j.xcrm.2021.100225"},{"key":"65","doi-asserted-by":"crossref","unstructured":"65\uff09Emmelot ME, Bodewes R, Maissan C, et al. Impact of genotypic variability of measles virus T-cell epitopes on vaccine-induced T-cell immunity. NPJ Vaccines 2025; 10(1): 36.","DOI":"10.1038\/s41541-025-01088-y"},{"key":"66","doi-asserted-by":"crossref","unstructured":"66\uff09Pueschel K, Tietz A, Carsillo M, Steward M, Niewiesk S. Measles virus-specific CD4 T-cell activity does not correlate with protection against lung infection or viral clearance. J Virol 2007; 81(16): 8571-8.","DOI":"10.1128\/JVI.00160-07"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67\uff09Lin WH, Pan CH, Adams RJ, Laube BL, Griffin DE. Vaccine-induced measles virus-specific T cells do not prevent infection or disease but facilitate subsequent clearance of viral RNA. mBio 2014; 5(2): e01047.","DOI":"10.1128\/mBio.01047-14"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68\uff09Nelson AN, Putnam N, Hauer D, Baxter VK, Adams RJ, Griffin DE. Evolution of T Cell Responses during Measles Virus Infection and RNA Clearance. Sci Rep 2017; 7(1): 11474.","DOI":"10.1038\/s41598-017-10965-z"},{"key":"69","doi-asserted-by":"crossref","unstructured":"69\uff09Amurri L, Reynard O, Gerlier D, Horvat B, Iampietro M. Measles Virus-Induced Host Immunity and Mechanisms of Viral Evasion. Viruses 2022; 14(12).","DOI":"10.3390\/v14122641"},{"key":"70","doi-asserted-by":"crossref","unstructured":"70\uff09Ackley SF, Hacker JK, Enanoria WTA, et al. Genotype-Specific Measles Transmissibility: A Branching Process Analysis. Clin Infect Dis 2018; 66(8): 1270-5.","DOI":"10.1093\/cid\/cix974"},{"key":"71","doi-asserted-by":"crossref","unstructured":"71\uff09El Mubarak HS, Yuksel S, van Amerongen G, et al. Infection of cynomolgus macaques (Macaca fascicularis) and rhesus macaques (Macaca mulatta) with different wild-type measles viruses. J Gen Virol 2007; 88(Pt 7): 2028-34.","DOI":"10.1099\/vir.0.82804-0"},{"key":"72","doi-asserted-by":"crossref","unstructured":"72\uff09Carter A, Msemburi W, Sim SY, et al. Modeling the impact of vaccination for the immunization Agenda 2030: Deaths averted due to vaccination against 14 pathogens in 194 countries from 2021 to 2030. Vaccine 2024; 42 Suppl 1: S28-S37.","DOI":"10.1016\/j.vaccine.2023.07.033"},{"key":"73","doi-asserted-by":"crossref","unstructured":"73\uff09Shattock AJ, Johnson HC, Sim SY, et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet 2024; 403(10441): 2307-16.","DOI":"10.1016\/S0140-6736(24)00850-X"},{"key":"74","doi-asserted-by":"crossref","unstructured":"74\uff09Lin WW, Moran E, Adams RJ, et al. A durable protective immune response to wild-type measles virus infection of macaques is due to viral replication and spread in lymphoid tissues. Sci Transl Med 2020; 12(537).","DOI":"10.1126\/scitranslmed.aax7799"},{"key":"75","doi-asserted-by":"crossref","unstructured":"75\uff09Parks CL, Lerch RA, Walpita P, Wang HP, Sidhu MS, Udem SA. Comparison of predicted amino acid sequences of measles virus strains in the Edmonston vaccine lineage. J Virol 2001; 75(2): 910-20.","DOI":"10.1128\/JVI.75.2.910-920.2001"},{"key":"76","doi-asserted-by":"crossref","unstructured":"76\uff09Bankamp B, Takeda M, Zhang Y, Xu W, Rota PA. Genetic characterization of measles vaccine strains. J Infect Dis 2011; 204 Suppl 1: S533-48.","DOI":"10.1093\/infdis\/jir097"},{"key":"77","doi-asserted-by":"crossref","unstructured":"77\uff09Bankamp B, Hodge G, McChesney MB, Bellini WJ, Rota PA. Genetic changes that affect the virulence of measles virus in a rhesus macaque model. Virology 2008; 373(1): 39-50.","DOI":"10.1016\/j.virol.2007.11.025"},{"key":"78","doi-asserted-by":"crossref","unstructured":"78\uff09Sharma LB, Ohgimoto S, Kato S, et al. Contribution of matrix, fusion, hemagglutinin, and large protein genes of the CAM-70 measles virus vaccine strain to efficient growth in chicken embryonic fibroblasts. J Virol 2009; 83(22): 11645-54.","DOI":"10.1128\/JVI.01110-09"},{"key":"79","doi-asserted-by":"crossref","unstructured":"79\uff09Nakatsu Y, Takeda M, Iwasaki M, Yanagi Y. A highly attenuated measles virus vaccine strain encodes a fully functional C protein. J Virol 2009; 83(22): 11996-2001.","DOI":"10.1128\/JVI.00791-09"},{"key":"80","doi-asserted-by":"crossref","unstructured":"80\uff09Fontana JM, Bankamp B, Bellini WJ, Rota PA. Regulation of interferon signaling by the C and V proteins from attenuated and wild-type strains of measles virus. Virology 2008; 374(1): 71-81.","DOI":"10.1016\/j.virol.2007.12.031"},{"key":"81","doi-asserted-by":"crossref","unstructured":"81\uff09Griffin DE. Measles Vaccine. Viral Immunol 2018; 31(2): 86-95.","DOI":"10.1089\/vim.2017.0143"},{"key":"82","doi-asserted-by":"crossref","unstructured":"82\uff09Takeda M, Ohno S, Tahara M, et al. Measles viruses possessing the polymerase protein genes of the Edmonston vaccine strain exhibit attenuated gene expression and growth in cultured cells and SLAM knock-in mice. J Virol 2008; 82(23): 11979-84.","DOI":"10.1128\/JVI.00867-08"},{"key":"83","doi-asserted-by":"crossref","unstructured":"83\uff09Schmitz KS, Rennick LJ, Tilston-Lunel NL, et al. Rational attenuation of canine distemper virus (CDV) to develop a morbillivirus animal model that mimics measles in humans. J Virol 2024; 98(3): e0185023.","DOI":"10.1128\/jvi.01850-23"},{"key":"84","doi-asserted-by":"crossref","unstructured":"84\uff09Hagan J, Dashpagma O, Vichit O, et al. Challenges for Sustaining Measles Elimination: Post-Verification Large-Scale Import-Related Measles Outbreaks in Mongolia and Cambodia, Resulting in the Loss of Measles Elimination Status. Vaccines (Basel) 2024; 12(7).","DOI":"10.3390\/vaccines12070821"},{"key":"85","doi-asserted-by":"crossref","unstructured":"85\uff09Chen CJ, Lee PI, Hsieh YC, et al. Waning population immunity to measles in Taiwan. Vaccine 2012; 30(47): 6721-7.","DOI":"10.1016\/j.vaccine.2012.05.019"},{"key":"86","doi-asserted-by":"crossref","unstructured":"86\uff09Kirby T. Global measles cases up 20% in 2023. Lancet Infect Dis 2025; 25(1): e17.","DOI":"10.1016\/S1473-3099(24)00827-2"},{"key":"87","doi-asserted-by":"crossref","unstructured":"87\uff09Wiedermann U, Garner-Spitzer E, Wagner A. Primary vaccine failure to routine vaccines: Why and what to do? Hum Vaccin Immunother 2016; 12(1): 239-43.","DOI":"10.1080\/21645515.2015.1093263"},{"key":"88","doi-asserted-by":"crossref","unstructured":"88\uff09Wang W, O'Driscoll M, Wang Q, Zhao S, Salje H, Yu H. Dynamics of measles immunity from birth and following vaccination. Nat Microbiol 2024; 9(7): 1676-85.","DOI":"10.1038\/s41564-024-01694-x"},{"key":"89","doi-asserted-by":"crossref","unstructured":"89\uff09Christenson B, Bottiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine 1994; 12(2): 129-33.","DOI":"10.1016\/0264-410X(94)90049-3"},{"key":"90","doi-asserted-by":"crossref","unstructured":"90\uff09Naniche D, Garenne M, Rae C, et al. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. J Infect Dis 2004; 190(8): 1387-95.","DOI":"10.1086\/424571"},{"key":"91","doi-asserted-by":"crossref","unstructured":"91\uff09Robert A, Suffel AM, Kucharski AJ. Long-term waning of vaccine-induced immunity to measles in England: a mathematical modelling study. Lancet Public Health 2024; 9(10): e766-e75.","DOI":"10.1016\/S2468-2667(24)00181-6"},{"key":"92","doi-asserted-by":"crossref","unstructured":"92\uff09Kontio M, Jokinen S, Paunio M, Peltola H, Davidkin I. Waning antibody levels and avidity: implications for MMR vaccine-induced protection. J Infect Dis 2012; 206(10): 1542-8.","DOI":"10.1093\/infdis\/jis568"},{"key":"93","doi-asserted-by":"crossref","unstructured":"93\uff09Marin M, Fiebelkorn AP, Bi D, et al. Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine. Clin Infect Dis 2021; 73(7): e1546-e53.","DOI":"10.1093\/cid\/ciaa1090"},{"key":"94","doi-asserted-by":"crossref","unstructured":"94\uff09Kaaijk P, Wijmenga-Monsuur AJ, van Houten MA, et al. A Third Dose of Measles-Mumps-Rubella Vaccine to Improve Immunity Against Mumps in Young Adults. J Infect Dis 2020; 221(6): 902-9.","DOI":"10.1093\/infdis\/jiz188"},{"key":"95","doi-asserted-by":"crossref","unstructured":"95\uff09Mehra S, Kludkleeb S, Chaimayo C, et al. Unveiling immunity gaps and determining a suitable age for a third dose of the measles-containing vaccine: a strategic approach to accelerating measles elimination. Lancet Reg Health Southeast Asia 2025; 32: 100523.","DOI":"10.1016\/j.lansea.2024.100523"},{"key":"96","doi-asserted-by":"crossref","unstructured":"96\uff09Kaaijk P, Wijmenga-Monsuur AJ, Ten Hulscher HI, et al. Antibody Levels at 3-Years Follow-Up of a Third Dose of Measles-Mumps-Rubella Vaccine in Young Adults. Vaccines (Basel) 2022; 10(1).","DOI":"10.3390\/vaccines10010132"},{"key":"97","doi-asserted-by":"crossref","unstructured":"97\uff09Kaaijk P, Nicolaie MA, van Rooijen D, et al. Dynamics of the Antibody Response After a Third Dose of Measles-Mumps-Rubella Vaccine Indicate a Slower Decline Compared With a Second Dose. Open Forum Infect Dis 2020; 7(11): ofaa505.","DOI":"10.1093\/ofid\/ofaa505"}],"container-title":["Uirusu"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/75\/1\/75_13\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T04:28:41Z","timestamp":1759552121000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsv\/75\/1\/75_13\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.2222\/jsv.75.13","relation":{},"ISSN":["0042-6857","1884-3433"],"issn-type":[{"type":"print","value":"0042-6857"},{"type":"electronic","value":"1884-3433"}],"subject":[],"published":{"date-parts":[[2025]]}}}